EBV latent membrane protein 1 is an attractive hypothesis as it up-regulates bcl-2, which has been shown to confer a survival advantage for lymphocytes in other lymphoproliferative disorders, and thus could enhance tissue lymphocyte accumulation and survival in LIP. This evidence concerns the gene BCL2 and medical procedure.